The board of directors (the “Board”) of IGEA Pharma N.V. (the “Company”) hereby
invites you to attend the Annual General Meeting on 09.11.2023 (the “AGM”) that will take
place at Tribes Amsterdam South Axis FOZ, Gustav Mahlerlaan 308, 1082 ME Amsterdam,
the Netherlands. The meeting will start at 14:00 hours CEST and is to be attended physically.
Registration will start at 13:00 hours CEST.
The Board hereby convenes this AGM. The Company urges all shareholders to attend the
meeting in person (or by proxy). Shareholders will have the possibility to vote manually or by
proxy, and they will have the possibility to ask questions about the agenda items (i) during
the AGM and (ii) prior to the AGM by submitting questions up to 72 hours prior to the AGM.
The convening notice, the agenda and the explanatory notes are available for inspection on
our website at https://www.igeapharma.nl/category/information-for-shareholders/.
Furthermore, these items can be obtained free of charge (i) by e-mail
at firstname.lastname@example.org; or by e-mail at email@example.com.
- Approval Annual Report 2022 (voting item)
- Proposal to adopt the annual accounts for the financial year 2022 (voting item)
- Proposal for discharge of liability of the members of the Board of Directors and
officers (voting item)
- Proposal of an audit firm
- Update on the appeal against the decision of SIX
2 Record date
You are entitled to participate in and vote at the AGM if you have these rights on 12 October
2023 after close of trading and processing of all settlements (the “Record Date”) and are
registered as such in one of the registers designated by the Board, provided that you have
registered to attend the AGM in accordance with the provisions set forth below.
If you wish to attend the AGM by proxy, you must notify Van Lanschot Kempen N.V. by email
to firstname.lastname@example.org through your bank or stockbroker (the “Intermediaries”).
Notification can take place as of the date hereof, but no later than 2 November 2023, 16:00
hours CEST. The Intermediaries must provide Van Lanschot Kempen N.V. with a statement
mentioning (i) the number of shares held by each of the shareholders on the Record Date on
whose behalf they make the registration and (ii) as per shareholder, for which number of
shares registration for the meeting is requested.
4 Voting by proxy
If you wish to have yourself represented at the AGM by a proxy holder, you may – in
addition to registering for the AGM as described above – grant a proxy to either (i) any
employee of Computershare Netherlands B.V., as independent third party, or (ii) another
person, to vote at the AGM on your behalf. The duly signed proxy instrument needs to be
received by no later than 2 November 2023, 16:00 hours CEST at Van Lanschot Kempen
N.V., Beethovenstraat 300, 1077 WZ Amsterdam and e-mail to email@example.com or
to firstname.lastname@example.org. A proxy form is available at the bottom.
5 Submission of questions before or during the AGM
Shareholders attending the AGM have the possibility to send questions about the agenda
items addressed to the General Meeting up to 72 hours prior to the AGM via e-mail
to email@example.com. The Company will address these questions either before the AGM on
its website, or during the AGM, possibly in a bundled form. The answers to these questions
will be published on the website of the Company. There is also a possibility to submit
questions during the AGM. The Chairman of the meeting may further determine this in the
interest of the order the meeting.
For further information, please do not hesitate to contact the Company at the Company’s
Offices at firstname.lastname@example.org.
6 Issued capital and voting rights of the Company
At the day of this notice, the Company has an issued share capital of EUR 3,467,141.42
consisting of 337,030,142 ordinary shares and 9,684,000 treasury shares, each having a
nominal value of EUR 0.01 The Company does not hold ordinary shares in its own capital.
Therefore, the total number of voting rights at the day of this notice amounts to 337,030,142.
Hoofddorp, 28 September 2023
The Board of Directors